Back to Main

Faculty Detail    
Associate Professor
Campus Address VH G019 Zip 0019
Phone 205-934-7070
Other websites

Undergraduate  University of Oklahoma    1985  BS in Zoology 
Graduate  University of Oklahoma Health Sciences Center    1996  Ph.D. in Pharmacology  

Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Pathology   Molecular & Cellular Pathology Associate Professor
Secondary  Pharmacology/Toxicology   Pharmacology/Toxicology Chair's Office Assistant Professor
Center  Medicine  Comprehensive Diabetes Ctr Associate Professor
Center  Medicine  Ctr Cardiovasc Bio Associate Professor
Center  Medicine  Nephrology Res & Trng Ctr Associate Professor

Graduate Biomedical Sciences Affiliations
Biochemistry and Structural Biology 
Integrative Biomedical Sciences 
Medical Scientist Training Program 
Pathobiology and Molecular Medicine 

Biographical Sketch 
Received Bachelor of Science in Zoology from the University of Oklahoma in 1989 Received PhD in Pharmacology from the University of Oklahoma Health Science Center, College of Medicine in 1996, Dissertation advisor: Lester A. Reinke, Dissertation title: Potential Mechanisms of Hepatic Ischemia-Reperfusion Injury. Postdoctoral Research Fellow, Department of Biochemistry, Wake Forest University School of Medicine from 3/96-2/99, Postdoctoral advisor: Carol C. Cunningham Instructor, Department of Biochemistry, Wake Forest University School of Medicine from 3/99-9/00 Assistant Professor, Department of Biochemistry, Wake Forest University School of Medicine from 10/00-8/01 Assistant Professor, Department of Environmental Health Sciences, School of Public Health, University of Alabama at Birmingham from 9/01-9/06 Associate Professor, Department of Environmental Health Sciences, School of Public Health, University of Alabama at Birmingham from 10/06 - 1/12; Associate Professor, Department of Pathology, Division of Molecular and Cellular Pathology, School of Medicine from 2/12 to present

Society Memberships
Organization Name Position Held Org Link
American Physiological Society  member 
Biochemical Society  member 
Research Society on Alcoholism  member 
Society for Free Radical Biology and Medicine  Editorial Board; member 

Research/Clinical Interest
Molecular mechanisms of chronic alcohol and obesity induced fatty liver disease
My research investigates how genetic, environmental, and life-style factors influence the initiation, progression, and severity of liver diseases and how these alterations impact risk for cardiovascular disease. Our studies are important for identifying a link between the severity of alcohol and obesity-related fatty liver disease (i.e., steatohepatitis) and increased risk for cardiovascular disease. Principal areas are focused on understanding how disruption in nitric oxide (NO) and hydrogen sulfide (H2S) signaling, and changes to mitochondria, contribute to pathology (liver disease, cardiovascular disease, and cancer). We are also interested in determining how disruption in cellular circadian rhythms or ‘clocks’ contribute to liver disease.

Selected Publications 
Publication PUBMEDID
Carey HV, Martin SL, Horwitz BA, Yan L, Bailey SM, Podrabsky J, Ortiz RM, Storz JF, Wong RP, and Lathrop DA. Harnessing evolutionary adaptations to advance biomedicine: elucidating nature’s solution to heart, lung, and blood diseases, and sleep disorders. Circ Res 110(7):915-921 (2012). (PMC3321354)  22461362 
Stein A, Mao Z, Morrison JP, Fanucchi MV, Postlethwait EM, Patel RP, Kraus DW, Doeller JE, and Bailey SM. Metabolic and cardiac signaling effects of inhaled hydrogen sulfide and low oxygen in male rats. J Appl Physiol 112(10):1659-1669 (2012). (PMC3365405)  22403348 
Kharbanda KK, Todero SL, King AL, Osna NA, McVicker BL, Tuma DJ, Wisecarver JL, and Bailey SM. Betaine treatment prevents chronic ethanol-induced steatosis and alterations to the mitochondrial respiratory chain proteome. Int J Hepatol 2012:962183 (2012). (PMC3235488)   22187660 
Zelickson BR, Benavides GA, Johnson MS, Chacko BK, Venkatraman A, Landar A, Betancourt AM, Bailey SM, and Darley-Usmar V. Nitric oxide and hypoxia exacerbate alcohol-induced mitochondrial dysfunction in hepatocytes. Biochim Biophys Acta 1807(12):1573-1582 (2011). (PMC3217123)  21971515 
Feldstein AE and Bailey SM. Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease. Antioxid Redox Signal 15(2):421-424 (2011). (PMC3118602).  21254858 
Eccleston HB, Andringa KK, Betancourt AM, King AL, Mantena SK, Swain, TM, Tinsley HN, Nolte RN, Nagy TR, Abrams GA, and Bailey SM. Chronic exposure to a high fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. Antioxid Redox Signal 15(2):447-459 (2011). (PMC3118652)  20919931 
Oliva CR, Diers A, McClugage SG, Sarkaria JN, Markert JM, Darley-Usmar VM, Bailey SM, Gillespie GY, Landar A, Griguer CE. Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem 285(51)39759-67 (2010). (PMC30000957)  20870728 
King AL, Swain TM, Dickinson DA, Lesort MJ, and Bailey SM. Chronic ethanol consumption enhances sensitivity to Ca2+-mediated opening of the mitochondrial permeability transition pore and increases cyclophilin D in liver. Am J Physiol Gastrointest Liver Physiol 299(4):G954-966 (2010). (PMC2957342)  20651005 
Andringa KK and Bailey SM. Detection of protein thiols in mitochondrial oxidative phosphorylation complexes and associated proteins. Methods Enzymol 474:83-108 (2010).  20609906 
Hill BG, Dranka BP, Bailey SM, Lancaster, JR, and Darley-Usmar VM. What part of NO don’t you understand? Some answers to the cardinal questions in nitric oxide biology. J Biol Chem 285(26):19699-19704 (2010).   20410298 
Bearer CF, Bailey SM, and Hoek JB. Advancing alcohol biomarkers research. Alcohol Clin Exp Res 34(6): 941-945 (2010).  20374221 
Andringa KK, King AL, Eccleston HE, Mantena SK, Landar A, Jhala NC, Dickinson DA, Squadrito GL, and Bailey SM. Analysis of the liver mitochondrial proteome in response to ethanol and S-adenosylmethionine treatment: novel molecular targets of disease and hepatoprotection. Am J Physiol Gastrointest Liver Physiol 298(5):G732-745 (2010). (PMC2867419)  20150243 
Bailey SM, Mantena SK, Cakir Y, Chhieng D, Pinkerton KE, and Ballinger SW. Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE-/- mouse: implications for a "multi-hit" hypothesis of fatty liver disease. Free Radic Biol Med 46:928-938 (2009). (PMC2775483)  19280709 
Mantena SK, Vaughn Jr DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE Kraus DW, Darley-Usmar VM, and Bailey SM. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417(1):183-193 (2009). (PMC2637578)  18752470 

Molecular mechanisms of alcohol and obesity induced liver diseases; Mitochondrial dysfunction in disease; Molecular bioenergetics; Circadian biology; Functional proteomics; Nitric oxide; Free radical biology; Toxicology